Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 78151-78200 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT07195760
Delayed IntraCranial Hemorrhage in Oral AntiCoagulant Treated Patients With Mild Traumatic Brain Injury
N/A
Active, not recruiting
600 participants
Started: Feb 10, 2023 · Completed: Jan 31, 2027
4 conditions
1 sponsor
1 location
NCT06277011
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research
EARLY_PHASE1
Recruiting
18 participants
Started: Feb 10, 2023 · Completed: May 15, 2025
2 conditions
2 sponsors
1 location
NCT05739981
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
PHASE1/PHASE2
Recruiting
50 participants
Started: Feb 10, 2023 · Completed: Jan 30, 2028
3 conditions
2 sponsors
4 locations
NCT04390971
Safety and Efficacy Evaluation of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia
NA
Active, not recruiting
3 participants
Started: Feb 10, 2023 · Completed: Aug 15, 2025
1 condition
4 sponsors
3 locations
NCT05672992
Longitudinal Spatial Frequency Domain Imaging Study
NA
Recruiting
92 participants
Started: Feb 10, 2023 · Completed: Jun 30, 2026
1 condition
3 sponsors
1 location
NCT05485753
A Study of GNC-038, a Tetra-specific Antibody, in Patients With Central Nervous System Lymphoma (PCNSL) and Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)
PHASE1/PHASE2
Active, not recruiting
7 participants
Started: Feb 10, 2023 · Completed: Dec 31, 2025
2 conditions
3 sponsors
4 locations
NCT05668858
A Study of SI-B001+SI-B003± Chemotherapy in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma
PHASE1/PHASE2
Recruiting
130 participants
Started: Feb 10, 2023 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT07115576
Single-Session Radiofrequency Ablation for the Treatment of Benign Thyroid Nodules: A Prospective Study
NA
Active, not recruiting
130 participants
Started: Feb 10, 2023 · Completed: Apr 10, 2026
1 condition
2 sponsors
1 location
NCT05936190
Comparison of the Effect of Lidocaine Infusion Applied at Different Doses During Lumbar Spinal Surgery on Hemodynamics and Postoperative Pain
NA
Recruiting
80 participants
Started: Feb 10, 2023 · Completed: Jan 31, 2024
3 conditions
3 sponsors
1 location
NCT06221202
Stories in the Moment: Dance Program for People Living With Dementia
NA
Recruiting
72 participants
Started: Feb 10, 2023 · Completed: Oct 31, 2024
6 conditions
2 sponsors
1 location
NCT05451004
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
PHASE3
Recruiting
510 participants
Started: Feb 10, 2023 · Completed: Aug 30, 2031
1 condition
5 sponsors
30 locations
NCT05605899
Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma
PHASE3
Recruiting
300 participants
Started: Feb 10, 2023 · Completed: Mar 31, 2031
1 condition
1 sponsor
90 locations
NCT05706168
Effects of Aerobic Exercise on the Cerebral Arterial System, Cognitive, and Motor Function in Post-stroke Patients.
NA
Recruiting
120 participants
Started: Feb 10, 2023 · Completed: Aug 31, 2024
1 condition
1 sponsor
1 location
NCT05730140
The Association Between the Intraoperative Blood Pressure Changes and Whole Exome Genome
N/A
Not yet recruiting
30 participants
Started: Feb 10, 2023 · Completed: Dec 31, 2030
1 condition
1 sponsor
0 locations
NCT05660642
An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression
PHASE2
Active, not recruiting
64 participants
Started: Feb 10, 2023 · Completed: Jul 31, 2025
1 condition
1 sponsor
3 locations
NCT05136131
QOL Improvement After Cardioversion of Persistent AF (QOL-CAFRCT)
NA
Recruiting
100 participants
Started: Feb 10, 2023 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT05555862
Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL
PHASE2
Active, not recruiting
17 participants
Started: Feb 10, 2023 · Completed: Dec 31, 2026
6 conditions
5 sponsors
2 locations
NCT05521867
Endoscopic Balloon Dilation Versus Endoscopic Stricturotomy for Short Crohn's Strictures
NA
Active, not recruiting
96 participants
Started: Feb 10, 2023 · Completed: Apr 9, 2026
1 condition
1 sponsor
1 location
NCT06110819
Individual Training Given to Pregnant Women in the Earthquake Zone in Their Living Spaces,
NA
Recruiting
64 participants
Started: Feb 9, 2023 · Completed: Dec 30, 2023
1 condition
1 sponsor
1 location
NCT06144515
Collection of Samples of Bone Marrow Aspiration From Patients With Myelodysplastic Syndrome
N/A
Active, not recruiting
100 participants
Started: Feb 9, 2023 · Completed: Mar 1, 2026
1 condition
1 sponsor
1 location
NCT05561205
rTMS for Apathy Clinical Trial
NA
Recruiting
10 participants
Started: Feb 9, 2023 · Completed: Dec 1, 2025
6 conditions
1 sponsor
1 location
NCT05385965
Meaning-Centered Pain Coping Skills Training for Cancer Pain
NA
Recruiting
210 participants
Started: Feb 9, 2023 · Completed: Mar 26, 2026
2 conditions
2 sponsors
1 location
NCT05530304
Outcome of a Triple Inner Branched Aortic Arch Stentgraft. A Prospective, Multicenter Registry.
N/A
Recruiting
30 participants
Started: Feb 9, 2023 · Completed: Mar 31, 2027
4 conditions
1 sponsor
1 location
NCT05818982
To Evaluate the Efficacy and Safety of Afatinib for Advanced ALTRK-negative ESCC
PHASE2
Recruiting
72 participants
Started: Feb 9, 2023 · Completed: Feb 28, 2026
1 condition
1 sponsor
3 locations
NCT05805189
Prospective Evaluation of Biophysical Parameters as Long-term Predictors of Pulmonary Vein Isolation
NA
Recruiting
60 participants
Started: Feb 9, 2023 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05664971
JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer
PHASE1/PHASE2
Active, not recruiting
119 participants
Started: Feb 9, 2023 · Completed: Nov 17, 2025
1 condition
1 sponsor
1 location
NCT05734651
PROMIS Evaluation Study
N/A
Recruiting
200 participants
Started: Feb 9, 2023 · Completed: Feb 9, 2042
5 conditions
2 sponsors
1 location
NCT04826237
Oral Statins and Protection From Hearing Loss
PHASE4
Recruiting
100 participants
Started: Feb 9, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05913960
Accelerated Intermittent Theta-Burst Stimulation Ameliorate Major Depressive Disorder by Regulating CAMKII Pathway
NA
Recruiting
90 participants
Started: Feb 9, 2023 · Completed: Mar 15, 2027
2 conditions
1 sponsor
1 location
NCT05546866
Study to Assess the Efficacy and Safety of Adjuvant Osimertinib in NSCLC With Uncommon EGFRm
PHASE2
Active, not recruiting
51 participants
Started: Feb 9, 2023 · Completed: Jun 30, 2029
1 condition
1 sponsor
10 locations
NCT05660798
Effects of Switching From Cigarettes to Tobacco Heating System on Coronary Atherosclerosis Progression
NA
Recruiting
180 participants
Started: Feb 9, 2023 · Completed: Dec 31, 2025
3 conditions
2 sponsors
1 location
NCT05536713
Understanding Patient Preference on Colorectal Cancer Screening Options
N/A
Recruiting
500 participants
Started: Feb 9, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06043661
Early Detection of Breast Cancer
N/A
Recruiting
700 participants
Started: Feb 9, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05757739
Randomized Controlled Trial (RCT) of Open Debridement Versus Tenex
N/A
Recruiting
90 participants
Started: Feb 9, 2023 · Completed: Jun 30, 2026
1 condition
6 sponsors
5 locations
NCT05627011
Dissemination and Implementation of Improving Pediatric Obesity Practice Using Prompts
NA
Active, not recruiting
240,772 participants
Started: Feb 9, 2023 · Completed: Dec 31, 2025
1 condition
2 sponsors
3 locations
NCT05696873
CoPing strategIes-psyChological flexibiliTy in Patients Hospitalized for Ischemic cardiovascUlaR disEase (PICTURE)
N/A
Recruiting
80 participants
Started: Feb 9, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05710432
Muscle Recruitment During Neck Flexion and Inspiratory Muscle Training
NA
Recruiting
10 participants
Started: Feb 9, 2023 · Completed: Nov 15, 2025
2 conditions
1 sponsor
1 location
NCT05736419
A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
PHASE2
Recruiting
24 participants
Started: Feb 9, 2023 · Completed: Feb 9, 2026
3 conditions
1 sponsor
6 locations
NCT05565807
Safety and Efficacy Study of An Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma
PHASE1/PHASE2
Recruiting
84 participants
Started: Feb 9, 2023 · Completed: Feb 19, 2028
1 condition
1 sponsor
4 locations
NCT06290661
Clinical Trial of the Safety and Efficacy of Peripheral Nerve Stimulation in the Treatment of Peripheral Neuropathic Pain.
NA
Recruiting
60 participants
Started: Feb 9, 2023 · Completed: Dec 30, 2026
3 conditions
4 sponsors
1 location
NCT05633979
Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab Deruxtecan in Subjects With HER2 Low/Ultra-low/Null Metastatic Breast Cancer
PHASE1
Recruiting
37 participants
Started: Feb 9, 2023 · Completed: Dec 31, 2032
1 condition
2 sponsors
1 location
NCT05501054
Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.
PHASE1/PHASE2
Active, not recruiting
50 participants
Started: Feb 9, 2023 · Completed: Nov 1, 2026
1 condition
1 sponsor
3 locations
NCT05659927
Single Dose Clinical Trial of MG-ZG122 in Chinese Healthy Adult Subjects
PHASE1
Active, not recruiting
34 participants
Started: Feb 9, 2023 · Completed: Mar 23, 2024
1 condition
1 sponsor
1 location
NCT05533164
Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Experiencing a PMR Relapse
PHASE3
Recruiting
174 participants
Started: Feb 9, 2023 · Completed: Jan 31, 2028
1 condition
3 sponsors
1 location
NCT05715307
Chinese Endocrinologists Health Education Study
NA
Active, not recruiting
2,017 participants
Started: Feb 9, 2023 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT06584162
Subcutaneous Interval Lengthening of Vedolizumab for Economic Research
PHASE4
Recruiting
40 participants
Started: Feb 9, 2023 · Completed: Feb 1, 2026
1 condition
1 sponsor
1 location
NCT04718792
Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study
PHASE2
Active, not recruiting
10 participants
Started: Feb 9, 2023 · Completed: Jul 21, 2024
1 condition
2 sponsors
1 location
NCT05279664
RIC-NEC Randomized Controlled Trial
PHASE2
Recruiting
78 participants
Started: Feb 9, 2023 · Completed: May 1, 2027
1 condition
14 sponsors
4 locations
NCT05577026
Safe Prescription of Opioids in Primary Care
NA
Active, not recruiting
52 participants
Started: Feb 9, 2023 · Completed: Mar 31, 2027
3 conditions
1 sponsor
1 location
NCT05734794
Study of Rituximab Monotherapy on Children With New-onset Nephrotic Syndrome: A Randomized Controlled Trial
PHASE3
Recruiting
80 participants
Started: Feb 9, 2023 · Completed: Jul 30, 2026
2 conditions
1 sponsor
1 location
Previous
1
More pages
1561
1562
1563
1564
1565
1566
1567
More pages
2369
Next